Formerly the Clinical Research Sequencing Platform, the cutting-edge laboratory at the Broad Institute is poised to further accelerate clinical genomics.
While the team launched new COVID-19 diagnostic and pathogen surveillance capabilities, they also analyzed more than 120,000 human genomes in 2021, with no slowdown in sight.
FedRAMP certification enables federal agencies, or federally funded projects, to engage more deeply with the cloud computing system for handling sensitive data.
Broad researchers are contributing to Massachusetts’s COVID-19 diagnostic testing, developing new diagnostic technologies and data analysis tools, and generating new biological insights.